MPOG QI Measures

2026 Provider Guide

*Not available for provider feedback

Please refer to: MPOG Measure Specs - Measure List for full specicaons and references used to determine measure

requirements. Contact support@mpog.zendesk.com with any quesons.

Measure Category

Measure

Descripon

Acute Kidney Injury

AKI-01

Creanine > 1.5x baseline with 7 days postop OR ≥ 0.3 mg/dL within 48

hours postop

Blood Pressure

BP-01

Low MAP prevenon < 55 (20 minutes)

BP-02

Avoiding monitoring gaps > 10 minutes (cumulave)

BP-03

Low MAP prevenon < 65 (15 minutes)

BP-05

Low MAP avoidance < 55 during inducon

BP-06

Low MAP prevenon < 55 (10 minutes)

Brain Health

BRAIN-01*

Avoiding benzodiazepine use in paents > 70 years old

Fluids

FLUID-01-NC

Minimizing colloid use in non-cardiac surgery

Glucose Management

GLU-09

Intraop hyperglycemia management > 180 mg/dL (10.00 mmol/L)

GLU-10

Periop hyperglycemia management > 180 mg/dL (10.00 mmol/L)

GLU-11

Periop hyperglycemia treatment > 180 mg/dL (10.00 mmol/L)

GLU-12

Intraop hypoglycemia management < 70 mg/dL (3.885 mmol/L)

GLU-13

Periop hypoglycemia management < 70 mg/dL (3.885 mmol/L)

Mortality

MORT-01*

30-Day in-hospital mortality rate

Myocardial Injury

CARD-04*

Postoperave Troponin for High-risk Paents

MPOG QI Measures

2026 Provider Guide

*Not available for provider feedback

Please refer to: MPOG Measure Specs - Measure List for full specicaons and references used to determine measure

requirements. Contact support@mpog.zendesk.com with any quesons.

Neuromuscular

Monitoring

NMB-01

Train-of-four measured

NMB-02

Reversal administered

NMB-04

Variaon in sugammadex administraon

NMB-05*

Quantave neuromuscular blockade monitoring

Pain Management

OPIOID*

Opioid equivalency

PAIN-02

Mulmodal non-opioid adjunct analgesia

PAIN-03

Opioid reversal with Naloxone

Postoperave Nausea and

Voming

PONV-03

Postoperave nausea or voming outcome

PONV-03b

Postoperave nausea or voming outcome with or without post-op

anemec

PONV-05

Postoperave nausea or voming prophylaxis

Pulmonary

PUL-01

Intraop median dal volume < 10 mL/kg PBW

PUL-03*

Median PEEP > 2 cm H

O during venlaon

Smoking Cessaon

SMOK-01

Smoking tobacco status documentaon

SMOK-02

Smoking tobacco cessaon educaon

Surgical Site Infecon

SSI-01-MSQC*

Surgical Site Infecon, Colectomy

Sustainability

SUS-01

Mean fresh gas ow < 3 L/min during maintenance phase

SUS-02

Mean CO

eq < 2.83 kg CO

/hr during maintenance phase

SUS-03*

eq reported as kg of CO

eq per case during inducon phase

SUS-04

Fresh gas ow < 2 L/min during maintenance phase

SUS-07

Nitrous oxide use avoided during case

SUS-08

Mean fresh gas ow < 1 L/min during maintenance phase

SUS-09

Mean fresh gas ow < 6L/min during inducon phase

MPOG QI Measures

2026 Provider Guide

*Not available for provider feedback

Please refer to: MPOG Measure Specs - Measure List for full specicaons and references used to determine measure

requirements. Contact support@mpog.zendesk.com with any quesons.

Temperature

TEMP-01

Temperature > 36.0 °C or use of acve warming documented within 30

minutes of anesthesia end

TEMP-02

At least one intraop core temperature documented

TEMP-03

At least one body temperature > 36 °C within 30 minutes before or 15

minutes aer anesthesia end

Transfer of Care

TOC-01

Intraop transfer of care in anesthesia record with key hando elements

TOC-02

Postop transfer of care in anesthesia record with key hando elements

TOC-03

ICU transfer of care in anesthesia record with key hando elements

Transfusion

TRAN-01

Documentaon of Hgb/Hct with 90 mins of prior blood transfusion

TRAN-02

Documentaon of post transfusion Hct/Hct > 10 g/dL or 30%

Measure Category

Measure

Descripon

Obstetrics

ABX-01-OB

Anbioc ming within one hour of cesarean delivery incision start

ABX-06 OB

Azithromycin Administraon for Cesarean Deliveries

BP-04-OB*

SBP < 90 mmHg for < 5 mins between spinal placement and delivery

GA-01-OB*

Cesarean delivery without general anesthesia

GA-02-OB*

Cesarean delivery with neuraxial anesthesia without general

anesthesia used

GA-03-OB*

Cesarean delivery with epidural anesthesia without general anesthesia

used

NCR-01-OB*

Neuraxial catheter replacement during obstetric anesthesia for labor

or cesarean delivery

TEMP-05-OB

At least one body temp > 36 °C within 30 mins before or aer

anesthesia end

MPOG QI Measures

2026 Provider Guide

*Not available for provider feedback

Please refer to: MPOG Measure Specs - Measure List for full specicaons and references used to determine measure

requirements. Contact support@mpog.zendesk.com with any quesons.

Measure Category

Measure

Descripon

Pediatrics

AKI-03-Peds

Pediatric cardiac cases with creanine > 1.5x baseline with 7 days

postop OR ≥ 0.3 mg/dL within 48 hours postop

FLUID-02-C*

Minimizing Colloid use in cardiac pediatric paents

FLUID-02-NC

Minimizing Colloid use in non-cardiac pediatric paents

NMB-03-Peds

NMB rst dose below expert opinion threshold

PAIN-01-Peds

At least one non-opioid adjunct administered preop or intraop

PONV-04-Peds

PONV prophylaxis between 4 hours prior to anesthesia start to PACU

start

SUS-05-Peds

Nitrous oxide avoided during inducon

SUS-06-Peds

Mean fresh gas ow less than weight-based max FGF during inducon

TEMP-04-Peds

Intraop median core or near core temperature > 36 °C

TRAN-03-Peds

Hgb/Hct documented within 90 mins prior to each transfusion volume

> 15 mL/kg

Measure Category

Measure

Descripon

Cardiac

ABX-02-C

Anbioc ming and administraon prior to incision

ABX-03-C

Cephalosporin re-dosing within 165-255 mins of previous dose

ABX-04-C

Anbioc selecon for surgical site infecon prophylaxis

ABX-05-C*

Composite measure for appropriate anbioc selecon, ming, re-

dosing for surgical site infecon prophylaxis

AKI-02-C

Creanine less than 1.5x baseline creanine within 7 days post or

creanine less than 0.3 mg/dL within 48 hours aer anesthesia end

BP-07-C*

MAP < 55 mmHg < 5 minutes during inducon or MAP > 55 mmHg

throughout inducon

FLUID-01-C

Avoidance of colloids during cardiac cases

GLU-06-C

Glucose < 180 mg/dL or re-check within 30 mins of glucose > 180

mg/dL (9.99 mmol/L)

MPOG QI Measures

2026 Provider Guide

*Not available for provider feedback

Please refer to: MPOG Measure Specs - Measure List for full specicaons and references used to determine measure

requirements. Contact support@mpog.zendesk.com with any quesons.

GLU-07-C

Glucose maintained > 70 mg/dL or re-check within 15 mins if < 70

mg/dL (3.88 mmol/L)

GLU-08-C

For glucose > 180 mg/dL, treatment of insulin with 30 mins or glucose

re-check within 30 minutes and glucose < 180 mg/dL (9.99 mmol/L)

GLU-14-C

Last intraoperave blood glucose level is ≤180 mg/dL (10.0 mmol/L)

TEMP-06-C

Hypothermia avoidance, core temperature at > 37.5 °C (99.5 °F) at

anesthesia end

TEMP-07-C

Hyperthermia avoidance, less than 5 consecuve mins of body temp >

37.5 °C (99.5 °F) between bypass start and end

TRAN-05-C*

Coagulaon tesng performed for cardiac paents who received a

transfusion.